James Biggins is the founder of Access Vascular. Access Vascular has raised $42M in total funding. Latest round: Series C. Backed by TVM Capital Life Science.
James Biggins is the Founder, CEO & President of Access Vascular, a company specializing in advanced biomaterial technology for vascular access devices. Access Vascular aims to reduce complications like bacterial adhesion and thrombus accumulation through its MIMIX™ hydrophilic biomaterial. The company secured a $22 million Series C funding round in 2023, following a $20 million Series B round in 2021. Biggins founded Access Vascular in 2015, leveraging his background in materials engineering and extensive experience in the medical device industry.
Full founder directory · Investor directory · Company funding database · Fundraising library